Growth hormone (GH) therapy in GH-deficient patients, the plasma factor VIII-von willebrand factor complex, and capillary fragility. A double-blind, placebo-controlled crossover study

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 50, Issue 4, 1990, Pages 417-420

  Jorgensen J O L ^a   Pedersen, S A ^b   Ingerslev, J ^a   Moller F J ^a   Christiansen, J S ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Factor VIII; Fibrinogen; Fibronectin; Plasminogen activator; Vascular resistance; Von Willebrand factor

Indexed keywords

BLOOD CLOTTING FACTOR 8; FIBRINOGEN; FIBRONECTIN; GROWTH HORMONE; PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; CAPILLARY WALL; FEMALE; GROWTH HORMONE DEFICIENCY; HEMOSTASIS; HUMAN; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; CAPILLARY FRAGILITY; DOUBLE-BLIND METHOD; ERYTHROCYTE INDICES; FACTOR VIII; FEMALE; GROWTH HORMONE; HEMATOCRIT; HUMAN; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MALE; PLACEBOS; VON WILLEBRAND FACTOR;

EID: 0025350142     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365519009091600     Document Type: Article

References (18)

1. Effects of growth hormone on the Factor VIII complex in patients with growth hormone deficiency
2. Diabetes-like alterations in haemostatic parameters after one week's growth hormone administration in normal man
3. Relation between growth hormone levels and von Willebrand factor activity
4. Twenty-five hour variations of von Willebrand factor and Factor VHI-related antigen in diabetic retinopathy
5. Effects of growth hormone, glucose and insulin on the Factor VIII complex
6. Diabetes, diabetic angiopathy, and growth hormone
7. Quantitative measurements of skin capillary resistance in hypo-physectomized long-term diabetics
8. Haemostatic variables associated with diabetes and its complications
9. Beneficial effects of growth hormone therapy in GH deficient adults
10. Enzyme-linked immunosorbent assay (ELISA) for Factor VIII coagulant antigen (CAg) using haemophilic antibodies
11. A sensitive ELISA for von Willebrand factor (vWf: Ag)
12. Quantitative estimation of proteins by electrophoresis in agarose gels containing antibodies
13. Wick chromatography for rapid and reliable immunoassay of insulin, glucagon and growth hormone
14. Dose-response studies with biosynthetic human growth hormone (GH) in GH deficient patients
15. Capillary fragility and diabetic retinopathy
16. Capillary fragility studies in diabetes
17. Diurnal patterns of blood glucose, serum free fatty acids, insulin, glucagon and GH in normal and juvenile diabetes